Metraipolis › archive › dc_aeafb10e4057

Optimizing the clinical assessment of pseudoprogression in patients with solid tumors treated with checkpoint inhibitors: a systematic literature review and… — Europe PMC PMID:42257909

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42257909
DOI
10.1007/s00262-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-10-08T14:08:36.342Z
SHA-256 of the archived text
84296312e65d752e7fe294561b90fc90a5e427d527ba630e77b6ad9c1859c6df
Stable URL of this page
https://metraipolis.com/documento/dc_aeafb10e4057

How to cite

Optimizing the clinical assessment of pseudoprogression in patients with solid tumors treated with checkpoint inhibitors: a systematic literature review and… — Europe PMC PMID:42257909 — Europe PMC (en), https://europepmc.org/article/MED/42257909 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aeafb10e4057 (Metraipolis archive dc_aeafb10e4057, sha256 84296312e65d752e7fe294561b90fc90a5e427d527ba630e77b6ad9c1859c6df)
BibTeX
@misc{dcaeafb10e4057,
  title = {Optimizing the clinical assessment of pseudoprogression in patients with solid tumors treated with checkpoint inhibitors: a systematic literature review and… — Europe PMC PMID:42257909},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42257909},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aeafb10e4057; sha256 84296312e65d752e7fe294561b90fc90a5e427d527ba630e77b6ad9c1859c6df},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42257909. Agents can read the archived copy with the MCP tool read_document.